Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vericel Corp VCEL

Healthcare Biotechnology
Vericel Corporation is a fully-integrated, commercial-stage biopharmaceutical company. The Company is a provider of advanced therapies for the sports medicine and severe burn care markets. It markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic... see more

Recent & Breaking News (NDAQ:VCEL)

Vericel Announces Termination of Shareholder Rights Agreement

GlobeNewswire February 12, 2021

Vericel to Report Fourth-Quarter 2020 Financial Results on February 24, 2021

GlobeNewswire February 10, 2021

Vericel Announces Appointment of Joe Mara as Chief Financial Officer

GlobeNewswire January 25, 2021

Vericel Announces Preliminary Fourth-Quarter and Full-Year 2020 Financial Results and Provides Business Updates

GlobeNewswire January 11, 2021

Vericel to Present at the 23rd Annual Needham Growth Conference on Friday, January 15, 2021

GlobeNewswire January 8, 2021

Vericel Announces Expansion of MACI Coverage by UnitedHealthcare to Include Patella and Multiple Cartilage Defects in the Knee

GlobeNewswire January 7, 2021

Vericel to Present at the 39th Annual J.P. Morgan Healthcare Conference on Thursday, January 14, 2021

GlobeNewswire December 18, 2020

Vericel Reports Record Third Quarter Revenues and Net Income

GlobeNewswire November 5, 2020

Vericel to Present at Upcoming Investor Conferences

GlobeNewswire November 2, 2020

Vericel to Report Third-Quarter 2020 Financial Results on November 5, 2020

GlobeNewswire October 22, 2020

Vericel Announces Preliminary Third Quarter 2020 Total Net Revenues of $32 Million

GlobeNewswire October 14, 2020

Vericel To Host Virtual Analyst and Investor Day on October 16, 2020

GlobeNewswire October 9, 2020

Vericel Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns

GlobeNewswire September 16, 2020

MediWound Announces FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns

GlobeNewswire September 16, 2020

Vericel to Present at Multiple Upcoming Investor Conferences

GlobeNewswire September 9, 2020

Vericel to Present at the 18th Annual Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2020

GlobeNewswire September 4, 2020

MediWound and Vericel Announce Acceptance of the First Delivery of NexoBrid to BARDA for Emergency Response Preparedness

GlobeNewswire August 25, 2020

Vericel Reports Second Quarter 2020 Financial Results

GlobeNewswire August 5, 2020

Vericel to Report Second-Quarter 2020 Financial Results on August 5, 2020

GlobeNewswire July 22, 2020

Vericel Announces Preliminary Second Quarter 2020 Financial Results and Provides Business Updates

GlobeNewswire July 9, 2020